Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Thorne Healthtech stock

Learn how to easily invest in Thorne Healthtech stock.

Health technology company Thorne HealthTech wrapped a downsized initial public offering Thursday, selling 7 million shares at $10 each, well below the $13 to $15 pricing range previously announced.

Shares of THRN debuted on the Nasdaq at $8.50.

How to buy shares in Thorne Healthtech

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – THRN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Thorne Healthtech stock price (NASDAQ: THRN)

Use our graph to track the performance of THRN stocks over time.

Thorne Healthtech shares at a glance

Information last updated 2022-09-27.
Latest market close$4.78
52-week range$4.00 - $10.13
50-day moving average $5.12
200-day moving average $5.54
Wall St. target price$8.25
PE ratio 100.4
Dividend yield $0 (0%)
Earnings per share (TTM) $0.05

Buy Thorne Healthtech shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Thorne Healthtech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Thorne Healthtech price performance over time

Historical closes compared with the close of $4.78 from 2022-09-29

1 week (2022-09-23) -3.24%
1 month (2022-09-01) 3.46%
3 months (2022-07-01) 1.70%
6 months (2022-04-01) -31.12%
1 year (2021-10-01) -43.63%
2 years (2020-09-27) N/A
3 years (2019-09-27) N/A
5 years (2017-09-27) N/A

Is Thorne Healthtech stock undervalued or overvalued?

Valuing Thorne Healthtech stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thorne Healthtech's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Thorne Healthtech's P/E ratio

Thorne Healthtech's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 100x. In other words, Thorne Healthtech shares trade at around 100x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Thorne Healthtech's P/E ratio is best considered in relation to those of others within the packaged foods industry or those of similar companies.

Thorne Healthtech's EBITDA

Thorne Healthtech's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.8 million.

The EBITDA is a measure of a Thorne Healthtech's overall financial performance and is widely used to measure a its profitability.

To put Thorne Healthtech's EBITDA into context you can compare it against that of similar companies.

Thorne Healthtech financials

Revenue TTM $208.6 million
Gross profit TTM $97.4 million
Return on assets TTM -0.5%
Return on equity TTM 1.6%
Profit margin 0.97%
Book value $2.34
Market capitalisation $264.8 million

TTM: trailing 12 months

Thorne Healthtech share dividends

We're not expecting Thorne Healthtech to pay a dividend over the next 12 months.

You may also wish to consider:

Thorne Healthtech overview

Thorne HealthTech, Inc. , a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

Frequently asked questions

What percentage of Thorne Healthtech is owned by insiders or institutions?
Currently 77.463% of Thorne Healthtech shares are held by insiders and 11.612% by institutions.
How many people work for Thorne Healthtech?
Latest data suggests 496 work at Thorne Healthtech.
When does the fiscal year end for Thorne Healthtech?
Thorne Healthtech's fiscal year ends in December.
Where is Thorne Healthtech based?
Thorne Healthtech's address is: 152 West 57th Street, New York, NY, United States, 10019
What is Thorne Healthtech's ISIN number?
Thorne Healthtech's international securities identification number is: US8852601090

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site